STOCK TITAN

Planned sale of 748 BIIB (NASDAQ: BIIB) shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of 748 shares of common stock of a NASDAQ-listed company has filed a notice of proposed sale under Rule 144. The shares have an aggregate market value of 134116.40 and are planned to be sold on 02/02/2026 through Fidelity Brokerage Services LLC on NASDAQ.

The securities were recently acquired on 02/01/2026 via restricted stock vesting from the issuer as compensation. The filer represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for BIIB disclose?

The filing discloses a planned sale of 748 common shares under Rule 144. The shares, valued at 134116.40 in total, are to be sold on NASDAQ through Fidelity Brokerage Services LLC, following recent acquisition via restricted stock vesting as compensation.

How many BIIB shares are planned for sale under this Form 144?

The notice covers a proposed sale of 748 shares of common stock. These shares have an aggregate market value of 134116.40 and are to be sold on NASDAQ through Fidelity Brokerage Services LLC on or about 02/02/2026, subject to market conditions and Rule 144 requirements.

How were the BIIB shares in this Form 144 acquired?

The 748 common shares were acquired on 02/01/2026 through restricted stock vesting from the issuer. The filing specifies the nature of payment as compensation, indicating the shares were not bought for cash but granted as part of a compensation arrangement.

When is the planned sale date for the BIIB shares in this Form 144?

The approximate date of sale listed is 02/02/2026 on NASDAQ. The sale is to be executed through Fidelity Brokerage Services LLC, consistent with Rule 144 requirements governing resale of restricted or control securities into the public market.

What assurances does the Form 144 filer give about BIIB information?

The person for whose account the securities will be sold represents they do not know any material adverse, non-public information about the issuer. This statement is required and is made as of signing the notice under the Rule 144 framework.
Biogen Inc

NASDAQ:BIIB

BIIB Rankings

BIIB Latest News

BIIB Latest SEC Filings

BIIB Stock Data

26.39B
146.45M
0.15%
92.56%
3.22%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE